

11 Feb 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260211298909/en/IntraBio-Reports-Further-Detail-on-Positive-Data-from-Levacetylleucine-Pivotal-Trial-for-the-Treatment-of-Ataxia-Telangiectasia

22 Jan 2026
// BUSINESSWIRE
https://www.businesswire.com/news/home/20260121091020/en/IntraBio-Announces-Positive-Pivotal-Trial-Results-of-Levacetylleucine-for-the-Treatment-of-Ataxia-Telangiectasia